{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:03:48Z","timestamp":1788897828763,"version":"build-2803163510"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1001\/jamaoto.2019.0034","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T15:31:15Z","timestamp":1553787075000},"page":"413","source":"Crossref","is-referenced-by-count":52,"title":["Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus\u2013Negative Oropharyngeal Cancers"],"prefix":"10.1001","volume":"145","author":[{"given":"Alexander J.","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery","family":"Gang","sequence":"additional","affiliation":[{"name":"Medical student at Washington University School of Medicine in Saint Louis, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan James","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Campian","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram","family":"Gay","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oppelt","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Rich","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal","family":"Paniello","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zevallos","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Hallahan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thorstad","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"ooi190002r1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"8","key":"ooi190002r2","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis.","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J Clin Invest"},{"issue":"15","key":"ooi190002r3","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-03-0760","article-title":"The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.","volume":"10","author":"De Larco","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ooi190002r4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00281-012-0344-6","article-title":"Protumor and antitumor functions of neutrophil granulocytes.","volume":"35","author":"Brandau","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"3","key":"ooi190002r5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","article-title":"Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.","volume":"23","author":"Dumitru","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"ooi190002r6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2613.2009.00641.x","article-title":"Neutrophils: key mediators of tumour angiogenesis.","volume":"90","author":"Tazzyman","year":"2009","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"ooi190002r7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/imr.2016.273.issue-1","article-title":"Neutrophils in cancer.","volume":"273","author":"Treffers","year":"2016","journal-title":"Immunol Rev"},{"issue":"6","key":"ooi190002r8","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ooi190002r9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cncr.29100","article-title":"Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.","volume":"121","author":"Huang","year":"2015","journal-title":"Cancer"},{"key":"ooi190002r10","doi-asserted-by":"publisher","first-page":"E1068","DOI":"10.1002\/hed.24159","article-title":"Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.","volume":"38","author":"Rachidi","year":"2016","journal-title":"Head Neck"},{"issue":"12","key":"ooi190002r11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hed.v36.12","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"issue":"1","key":"ooi190002r12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"ooi190002r13","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/s12105-012-0369-0","article-title":"p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma.","volume":"6","author":"Lewis","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"20","key":"ooi190002r14","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic importance of comorbidity in a hospital-based cancer registry.","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"ooi190002r16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.anl.2016.05.013","article-title":"Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy.","volume":"44","author":"Kim","year":"2017","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"ooi190002r17","first-page":"189","article-title":"Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.","volume":"7","author":"Hyder","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"ooi190002r18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non\u2013small cell lung cancer.","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"issue":"7","key":"ooi190002r19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hed.v40.7","article-title":"Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.","volume":"40","author":"Payne","year":"2018","journal-title":"Head Neck"},{"issue":"12","key":"ooi190002r20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1080\/095530099139106","article-title":"Biomarkers of exposure, sensitivity and disease.","volume":"75","author":"Brooks","year":"1999","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"ooi190002r21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/JOE-08-0512","article-title":"Endogenous galectins and the control of the host inflammatory response.","volume":"201","author":"Norling","year":"2009","journal-title":"J Endocrinol"},{"issue":"21","key":"ooi190002r22","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1158\/1078-0432.CCR-14-1138","article-title":"Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.","volume":"20","author":"Kuo","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"17","key":"ooi190002r23","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1158\/0008-5472.CAN-15-1412","article-title":"Stem cell transfusion restores immune function in radiation-induced lymphopenic C57BL\/6 mice.","volume":"75","author":"Kapoor","year":"2015","journal-title":"Cancer Res"},{"issue":"2","key":"ooi190002r24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"issue":"5","key":"ooi190002r25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ijrobp.2015.04.005","article-title":"Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma.","volume":"92","author":"Huang","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"August","key":"ooi190002r26","first-page":"1","article-title":"Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.","volume":"86","author":"Lin","year":"2018","journal-title":"Oral Oncol"},{"issue":"1","key":"ooi190002r27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiation for glioblastoma.","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"ooi190002r28","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijrobp.2015.07.168","article-title":"Eliminating radiation therapy to the pathologic node-negative neck does not increase the risk of regional recurrence: a prospective phase 2 trial.","volume":"93","author":"Spencer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"ooi190002r29","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/cncr.v123.23","article-title":"Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.","volume":"123","author":"Chin","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"ooi190002r30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-017-2668-5","article-title":"Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.","volume":"136","author":"Lin","year":"2018","journal-title":"J Neurooncol"},{"issue":"3","key":"ooi190002r32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.V87.3.900.bloodjournal873900","article-title":"Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men.","volume":"87","author":"Pollm\u00e4cher","year":"1996","journal-title":"Blood"},{"key":"ooi190002r34","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer.","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"ooi190002r37","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck.","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"32","key":"ooi190002r38","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1200\/JCO.2016.68.1478","article-title":"Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and\/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort.","volume":"34","author":"Chow","year":"2016","journal-title":"J Clin Oncol"},{"key":"ooi190002r39","first-page":"114268","article-title":"Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors.","volume":"8","author":"Diehl","year":"2017","journal-title":"J Clin Oncol"},{"key":"ooi190002r41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors.","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ooi190002r15","volume-title":"The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and the Interpretation of Research Results","author":"Ellis","year":"2015"},{"key":"ooi190002r31","volume-title":"DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles and Practice of Oncology","author":"DeVita","year":"2015","edition":"10th ed"},{"key":"ooi190002r33","unstructured":"ClinicalTrials.gov. Study of the effect IL-7\/NT-I7 on CD4 counts in patients with high grade gliomas. NCT02659800. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02659800. Accessed December 31, 2018."},{"key":"ooi190002r35","unstructured":"ClinicalTrials.gov. Study to compare avelumab in combination with standard of care chemoradiotherapy (SoC CRT) versus SoC CRT for definitive treatment in patients with locally advanced squamous cell carcinoma of the head and neck (JAVELIN HEAD AND NECK 100). NCT02952586. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02952586. Accessed December 31, 2018."},{"key":"ooi190002r36","unstructured":"ClinicalTrials.gov. Randomized trial of avelumab-cetuximab-radiotherapy versus SOCs in LA SCCHN (REACH). NCT02999087. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02999087. Accessed December 31, 2018."},{"key":"ooi190002r40","doi-asserted-by":"crossref","unstructured":"ArbourKC, MezquitaLM, LongN, . Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC. J Clin Oncol. June 5, 2018:suppl; abstr 9003. https:\/\/meetinglibrary.asco.org\/record\/160292\/abstract.","DOI":"10.1200\/JCO.2018.36.15_suppl.9003"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaotolaryngology\/article-pdf\/145\/5\/413\/17599052\/jamaotolaryngology_lin_2019_oi_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T12:38:43Z","timestamp":1574426323000},"score":1,"resource":{"primary":{"URL":"http:\/\/archotol.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoto.2019.0034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2019.0034","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}